VAG
GSK icon

VisionPoint Advisory Group’s GSK GSK Stock Holding History

VisionPoint Advisory Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,978
Closed -$410K – 136
2019
Q4 		$410K Buy
6,978
+854
+14% +$47.5K 0.17% 75
2019
Q3 		$321K Buy
6,124
+797
+15% +$41K 0.09% 90
2019
Q2 		$266K Buy
5,327
+375
+8% +$18.8K 0.08% 103
2019
Q1 		$259K Buy
+4,952
New +$247K 0.07% 109

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

VisionPoint Advisory Group's GSK Position: Q1 2020 in Review

VisionPoint Advisory Group sold out of GSK (GSK) in Q1 2020, closing a stake of 6,978 shares — an estimated $410K sold.

VisionPoint Advisory Group first reported a position in GSK in Q1 2019 and held it in 4 quarters. The position peaked at $410K in Q4 2019. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • VisionPoint Advisory Group reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • VisionPoint Advisory Group sold 6,978 GSK shares in Q1 2020, an estimated $410K.
  • VisionPoint Advisory Group first reported a position in GSK in Q1 2019 and held it in 4 quarters.
  • VisionPoint Advisory Group's GSK position peaked at $410K in Q4 2019.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on VisionPoint Advisory Group's 13F filing for Q1 2020, filed 15 May 2020.